In a study, researchers reviewed the growing global health concern of Alzheimer’s disease (AD), with its prevalence expected to double every 20 years, particularly in developing countries.
Study Highlights Urgent Need for Standardized Biomarkers in Alzheimer’s Disease Diagnosis and Management
Kate Bondaruk2024-10-04T18:26:17+00:00October 4th, 2024|Neurology|Comments Off on Study Highlights Urgent Need for Standardized Biomarkers in Alzheimer’s Disease Diagnosis and Management